Skip to main content

Jessica Hagen

By Jessica Hagen | 01:45 pm | February 01, 2023
AgeWell New York's CareWell members will have access to the VR company's immersive experiences designed for the aging population.
By Jessica Hagen | 02:28 pm | January 31, 2023
OncoPower users will have access to Cost Plus Drugs' prescriptions through the partners' Medication Savings Suite.
By Jessica Hagen | 11:29 am | January 31, 2023
Cough-monitoring company C-mo Medical Solutions and sexual healthcare provider TBD Health also announced funding rounds.
By Jessica Hagen | 02:01 pm | January 30, 2023
The funds will help the company continue to expand into new markets.
By Jessica Hagen | 01:55 pm | January 27, 2023
The funds will help the company grow its platform and scale partnerships with life science companies and healthcare systems.
By Jessica Hagen | 03:49 pm | January 26, 2023
Tia opened another LA-based clinic with Cedars-Sinai, and the partners will set up three more brick-and-mortar clinics in Pasadena, Studio City and Culver City.
By Jessica Hagen | 01:12 pm | January 26, 2023
In an exclusive interview, the companies discuss their partnership and TRIPP's investment in Equa Health's pre-seed funding round.
By Jessica Hagen | 11:25 am | January 26, 2023
The Tidepool Loop app connects to compatible continuous glucose monitors and pumps, and helps Type 1 diabetes patients determine whether insulin levels should be adjusted.
By Jessica Hagen | 02:50 pm | January 25, 2023
AI-based drug discovery platform Atomic AI, senior lifestyle company Mighty Health, Lithuania-based Oxipit and cybersecurity firm MedCrypt also closed funding rounds.
By Jessica Hagen | 05:08 pm | January 24, 2023
The FDA's Oncology Center of Excellence will use Aetion's Evidence Platform to find and analyze sources of real-world data that could be used for research.